These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19300612)

  • 1. Indiplon in the treatment of sleep disorders.
    Lankford A
    Neuropsychiatr Dis Treat; 2007 Dec; 3(6):765-73. PubMed ID: 19300612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indiplon: the development of a novel therapy for the treatment of sleep onset and sleep maintenance insomnia.
    Lankford A; Ancoli-Israel S
    Int J Clin Pract; 2007 Jun; 61(6):1037-45. PubMed ID: 17386060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia.
    Marrs JC
    Ann Pharmacother; 2008 Jul; 42(7):1070-9. PubMed ID: 18594049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
    J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indiplon in the management of insomnia.
    Lemon MD; Strain JD; Hegg AM; Farver DK
    Drug Des Devel Ther; 2009 Sep; 3():131-42. PubMed ID: 19920929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
    Sullivan SK; Petroski RE; Verge G; Gross RS; Foster AC; Grigoriadis DE
    J Pharmacol Exp Ther; 2004 Nov; 311(2):537-46. PubMed ID: 15256540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors.
    Petroski RE; Pomeroy JE; Das R; Bowman H; Yang W; Chen AP; Foster AC
    J Pharmacol Exp Ther; 2006 Apr; 317(1):369-77. PubMed ID: 16399882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK; Moscovitch A; Burke J; Farber R; Roth T
    Sleep Med; 2007 Nov; 8(7-8):753-9. PubMed ID: 17825616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of as-needed, post bedtime dosing with indiplon in insomnia patients with chronic difficulty maintaining sleep.
    Roth T; Zammit GK; Scharf MB; Farber R
    Sleep; 2007 Dec; 30(12):1731-8. PubMed ID: 18246982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosynthesis and biological evaluation of an 18F-labeled derivative of the novel pyrazolopyrimidine sedative-hypnotic agent indiplon.
    Hoepping A; Scheunemann M; Fischer S; Deuther-Conrad W; Hiller A; Wegner F; Diekers M; Steinbach J; Brust P
    Nucl Med Biol; 2007 Jul; 34(5):559-70. PubMed ID: 17591556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacological characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic.
    Foster AC; Pelleymounter MA; Cullen MJ; Lewis D; Joppa M; Chen TK; Bozigian HP; Gross RS; Gogas KR
    J Pharmacol Exp Ther; 2004 Nov; 311(2):547-59. PubMed ID: 15256538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indiplon: the development of a new hypnotic.
    Neubauer DN
    Expert Opin Investig Drugs; 2005 Oct; 14(10):1269-76. PubMed ID: 16185169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.
    Scharf MB; Black J; Hull S; Landin R; Farber R
    Sleep; 2007 Jun; 30(6):743-52. PubMed ID: 17580596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of indiplon in transient insomnia.
    Rosenberg R; Roth T; Scharf MB; Lankford DA; Farber R
    J Clin Sleep Med; 2007 Jun; 3(4):374-9. PubMed ID: 17694726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-aggregation effect on platelets of Indiplon a hypnotic sedative non-benzodiazepine drug.
    Burgos CF; Sanchéz C; Sepúlveda C; Fuentes E; Palomo I; Alarcón M
    Biomed Pharmacother; 2019 Mar; 111():378-385. PubMed ID: 30594050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
    Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
    Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indiplon. Indiplon modified-release, indiplon MR, NBI 34060, NBI 34060 modified-release, NBI 34060 MR.
    Drugs R D; 2002; 3(3):197-9. PubMed ID: 12099167
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.